Pharmacogenomics

Genetic variation that contributes to nicotine dependence
pp. 881-883(3)
Author: Bierut, Laura Jean

Researchers identify genetic mutation that may alter tumor cell proliferation
pp. 885-887(3)

RNAi extravaganza: from biochemistry to drugs and therapeutics
pp. 889-893(5)
Author: Appasani, Krishnarao

Glutathione S-transferases π1, α1 and µ3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans
pp. 895-899(5)
Authors: Ladero, José M; Martínez, Carmen; Fernández, Juana M; Martín, Felipe; García-Martín, Elena; Ropero, Paloma; Villegas, Ana; Díaz-Rubio, Manuel; Agúndez, José AG

Association between paraoxonase-1 Q192R polymorphism and lung function among Saskatchewan grain handlers
pp. 901-908(8)
Authors: Takayuki, Seo; Pahwa, Punam; McDuffie, Helen H; Shindo, Junichi; Goto, Shuji; Hashimoto, Mirai; Ghosh, Sunita; Nakagawa, Kazuko

Role of MED12 in transcription and human behavior
pp. 909-916(8)
Authors: Philibert, Robert A; Madan, Anup

Pharmacogenetics of thiazolidinedione therapy
pp. 917-931(15)
Author: Aquilante, Christina L

Pharmacogenetics of the response to β2 agonist drugs: a systematic overview of the field
pp. 933-958(26)
Authors: Contopoulos-Ioannidis, Despina G; Kouri, Ioanna; Ioannidis, John PA

Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions
pp. 959-969(11)
Authors: Laskowitz, Daniel T; Vitek, Michael P

miRNAs: from neurogeneration to neurodegeneration
pp. 971-978(8)
Author: Singh, Sunit Kumar

Gene therapy for erectile dysfunction
pp. 979-984(6)
Authors: Mills, Jesse N; Dall'Era, Joseph E; Carlsen, Soren N; Koul, Hari; Meacham, Randall B

G>C SNP of thymidylate synthase with respect to colorectal cancer
pp. 985-996(12)
Authors: Gusella, Milena; Padrini, Roberto

Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies
pp. 997-1003(7)
Authors: Zucman-Rossi, Jessica; Laurent-Puig, Pierre

Protein kinases as targets for cancer treatment
pp. 1005-1016(12)
Authors: Giamas, Georgios; Stebbing, Justin; Vorgias, Constantinos E; Knippschild, Uwe

Toxicogenomics of A375 human malignant melanoma cells
pp. 1017-1036(20)
Authors: Cheng, Sun-Long; Huang-Liu, Rosa; Sheu, Jin-Nan; Chen, Shui-Tein; Sinchaikul, Supachok; Tsay, Gregory J

Increasing the robustness and validity of RNAi screens
pp. 1037-1049(13)
Author: Haney, Steven A

Evidence-based management of nutrigenomics expectations and ELSIs
pp. 1051-1062(12)
Authors: Ozdemir, Vural; Godard, Béatrice

Characterization of the drugged human genome
pp. 1063-1073(11)
Authors: Lauss, Martin; Kriegner, Albert; Vierlinger, Klemens; Noehammer, Christa

Silent SNPs: impact on gene function and phenotype
pp. 1075-1080(6)
Author: Komar, Anton A

SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational models
pp. 1081-1084(4)
Author: Wills, Quin